Regis Jean-Pierre Simard
Net worth: 651 694 $ as of 2026-06-29
Net worth: 651 694 $ as of 2026-06-29
Regis Jean-Pierre Simard is currently the Director at ViiV Healthcare Ltd. and the President-Global Supply Chain at GSK Plc.
Previously, he served as the Non-Executive Director at GlaxoSmithKline Pharmaceuticals Ltd. from 2015 to 2017.
He also held a position as Director at Glaxo Operations UK Ltd.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GSK PLC 0% | 2026-07-09 | 24,786 ( 0% ) | 651 694 $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 2018-08-31 |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Director/Board Member | 2017-03-30 |
| Companies | Position | End |
|---|---|---|
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Director/Board Member | 2017-02-10 |
Glaxo Operations UK Ltd.
Glaxo Operations UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
GlaxoSmithKline Pharmaceuticals Ltd.
GlaxoSmithKline Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the business of manufacturing, distributing and trading in pharmaceuticals | Health Technology |
Glaxo Operations UK Ltd.
Glaxo Operations UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions